CorePharma Corp.

CDMO

Netherlands

https://corepharmacorp.com

Is this your company? Claim this profile

Analytical & Bioanalytical Services

Excipients & Specialty Ingredients

Regulatory, Tech Transfer & Support Services

Chemistry, Manufacturing and Controls

Company Overview

About

CorePharma Corp. is a leading contract development and manufacturing organization headquartered in Netherlands. We specialize in Biologics Manufacturer, Cell & Gene Therapy, Analytical Testing with state-of-the-art facilities serving clients globally.

Key Expertise

Biologics Drug Product, mRNA Production, Aseptic Processing, Fill/Finish (Cartridges), Supply Chain Management

Therapeutic Areas

Respiratory

Allergy

Quick Facts

HQ:Netherlands

Founded:2010

Employees:105

Capabilities & Services

Core Capabilities

Biologics Drug Substance
Biologics Manufacturing
Formulation Development

Types of Organization

Advanced Therapy Manufacturer (cell, gene, mRNA, ADC)

Biologics Manufacturer

Drug Substance / API Manufacturer

Formulation Development

Dosage Forms

Sterile Injectable

Containment Capabilities

OEB 4 (1-10 µg/m³)

Production Scales

Pilot Scale

Clinical

Commercial Scale

Batch Sizes

100L-1000L

1000L-5000L

Markets Served

Global

Manufacturing Facilities

3 sites worldwide

CorePharma Corp. - Headquarters

69 Science Park, Amsterdam, Amsterdam, 60742

View on Map

374,066 sq ft

Established 2015

Site Capabilities

6 capabilities

Fill/Finish (Vials)

Biologics Drug Substance

Small Molecule Drug Product

Small Molecule API

Antibody-Drug Conjugates (ADC)

Oral Solid Dose

CorePharma Corp. - Paris Facility

434 Industrial Way, Paris, Paris, 34020

View on Map

477,906 sq ft

Established 2020

Site Capabilities

3 capabilities

Cell & Gene Therapy

Supply Chain Management

Small Molecule Drug Product

CorePharma Corp. - Rotterdam Facility

675 Science Boulevard, Rotterdam, Rotterdam, 63954

View on Map

482,886 sq ft

Established 2000

Site Capabilities

3 capabilities

Small Molecule Drug Product

Small Molecule API

Fill/Finish (Cartridges)

Regulatory Approvals

Drug Approval P997CV

EMA · #APR-12X12XA9 · 2019-07-01

Drug Approval LYQR1Y

PMDA · #APR-W45XRH8C · 2021-11-01

Case Studies

0 published case studies showcasing past projects, challenges and outcomes.

Certifications

FDA Registration

U.S. Food and Drug Administration

Cert #: CERT-YNVWLTXX

Issued: 2020-11-24

Expires: 2025-05-23

EMA GMP Certificate

European Medicines Agency

Cert #: CERT-WCBMMF9Y

Issued: 2020-09-26

Expires: 2025-05-28

ISO 9001:2015

International Organization for Standardization

Cert #: CERT-O4E5I695

Issued: 2020-12-19

Expires: 2025-08-02

MHRA GMP

UK Medicines and Healthcare products Regulatory Agency

Cert #: CERT-RISGVYH9

Issued: 2020-11-12

Expires: 2025-08-16

Customer Reviews

4.1

Overall Rating(Based on 5 reviews)

Project Management4.9

Technology Transfer4.5

On-Time Delivery3.4

Communication Responsiveness4.3

Innovation3.5

Loading CDMO intelligence...

Request an Introduction

Please log in to contact this provider.

Key facts about CorePharma Corp.

CorePharma Corp. is headquartered in the Netherlands.
CorePharma Corp. was founded in 2010.
CorePharma Corp. has 105 employees.
CorePharma Corp. has 3 manufacturing sites listed on CDMO Hub, in Amsterdam, Netherlands, Paris, France and Rotterdam, Netherlands.
CorePharma Corp.'s capabilities include Biologics Drug Substance, Biologics Manufacturing and Formulation Development.

Find CDMOs like CorePharma Corp.

Directory pages this company appears in, each with the full list of matching manufacturers.

CDMOs in Netherlands CDMOs in Europe Biologics Drug Substance CDMOs Formulation Development CDMOs Sterile Injectable CDMOs OEB 4 (1-10 µg/m³) CDMOs

Key facts about CorePharma Corp.

CorePharma Corp. is headquartered in the Netherlands.

CorePharma Corp. was founded in 2010.

CorePharma Corp. has 105 employees.

CorePharma Corp. has 3 manufacturing sites listed on CDMO Hub, in Amsterdam, Netherlands, Paris, France and Rotterdam, Netherlands.

CorePharma Corp.'s capabilities include Biologics Drug Substance, Biologics Manufacturing and Formulation Development.